A
Alfresa Holdings Corp
TSE:2784
Alfresa Holdings Corp
TSE:2784
Price:
2 390 JPY
1.68%
Updated:
May 2, 2024
P/B
Price to Book Value
Price to Book Value
1
Current
0.7
Median
2.2
Industry
Higher
than median
Lower
than industry value
Price to Book Value (P/B) ratio is a valuation multiple that measures the market's valuation of a company relative to its book value. The P/B ratio is only considered useful in practice when applied to capital-intensive businesses.
P/B
=1
Market Cap
/
446.6B
Book Value of Equity
464B
All Countries
| Market Cap | P/B | ||||
|---|---|---|---|---|---|
| JP |
A
|
Alfresa Holdings Corp
TSE:2784
|
446.6B JPY | 1 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
69.6B USD | -33.9 | |
| US |
|
Cencora Inc
NYSE:COR
|
45.7B USD | 50.1 | |
| US |
|
Amerisourcebergen Corp
NYSE:ABC
|
35.4B USD | 51.5 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
24.9B USD | -7.2 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
8.9B USD | 2.4 | |
| KR |
C
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 6 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
57.6B CNY | 2.8 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
60.5B HKD | 0.8 | |
| IT |
|
Amplifon SpA
MIL:AMP
|
7.2B EUR | 6.5 | |
| CN |
S
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
51B CNY | 0.7 |
P/B Forward Multiples
Forward P/B multiple is a version of the P/B ratio that uses forecasted equity for the P/B calculation. 1-Year, 2-Years, and 3-Years forwards use equity forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/B
N/A
2-Years Forward
P/B
N/A
3-Years Forward
P/B
N/A
You don't have any saved screeners yet
